Nohara A, Kuriki H, Ishiguro T, Saijo T, Ukawa K, Maki Y, Sanno Y
J Med Chem. 1979 Mar;22(3):290-5. doi: 10.1021/jm00189a014.
The metabolites of 6-ethyl-3-(1H-tetrazol-5-yl)chromone (AA-344) (1), an orally effective antiallergic agent, and their analogues were synthesized to confirm the proposed structures and to determine their activity in the rat passive cutaneous anaphylaxis (PCA) test. A glucuronic acid metabolite (6) was assigned the structure 24b, 1-deoxy-1-[5-(6-ethylchromon-3-yl)tetrazol-1-yl]-beta-D-glucopyranuronate, by the comparison of 13C NMR, mass spectra, and TLC of isomeric compounds. In 13C NMR spectra, the shift difference of the tetrazole ring carbons between a pair of isomers was more remarkable than that of the glycosidic carbons. Therefore, the former is a useful criterion for distinguishing between such isomers. Some of the metabolities and analogues were active when administered intravenously, and two metabolites (2 and 3) were also effective upon oral administration.
6-乙基-3-(1H-四氮唑-5-基)色酮(AA-344)(1)是一种口服有效的抗过敏剂,合成了其代谢产物及其类似物,以确认所提出的结构,并在大鼠被动皮肤过敏反应(PCA)试验中测定它们的活性。通过比较异构体化合物的13C NMR、质谱和TLC,将一种葡萄糖醛酸代谢产物(6)指定为结构24b,即1-脱氧-1-[5-(6-乙基色酮-3-基)四氮唑-1-基]-β-D-吡喃葡萄糖醛酸酯。在13C NMR光谱中,一对异构体之间四氮唑环碳的位移差异比糖苷碳的位移差异更显著。因此,前者是区分此类异构体的有用标准。一些代谢产物和类似物静脉给药时有活性,两种代谢产物(2和3)口服给药也有效。